Comprehensive Pan-cancer Analysis of CMPK2 as Biomarker and Prognostic Indicator for Immunotherapy

CONCLUSION: Our analysis preliminarily describes the complex function of CMPK2 in cancer progression and immune microenvironment highlighting its potential as a diagnostic and therapeutic target for immunotherapy.PMID:38486392 | DOI:10.2174/0115680096281451240306062101

Source: Current Cancer Drug Targets - March 15, 2024 Category: Cancer & Oncology Authors: Jingyuan Luo Qianyue Zhang Shutong Wang Luojie Zheng Jie Liu Yuchen Zhang Yingchen Wang Ranran Wang Zhigang Xiao Zheng Li Source Type: research